Rapid PE Triage and Notification (PETN) vs PMcardio

PMcardio offers a mobile app and web platform, allowing for instant AI-powered ECG interpretations by simply scanning an ECG. This broad accessibility and ease of use, including a free plan, makes it highly usable for a wide range of clinicians at the point of care. Rapid PE Triage and Notification, while offering mobile access, is primarily integrated within a hospital's existing infrastructure and focuses on CTPA image analysis, which suggests a more specialized and less universally accessible workflow for individual clinicians.

PMcardio is clinically validated in over 25 studies and detects more than 50 cardiac conditions, including critical ones like STEMI/OMI and reduced LVEF, with high accuracy. It also provides AI explainability and patient management recommendations. Rapid PE Triage and Notification focuses on a single condition (central pulmonary embolism) and, while clinically validated with high sensitivity and specificity, its scope is narrower.

PMcardio offers a freemium model with a free plan for up to 5 ECG analyses per month, and transparent pricing for its Pro plan. This allows individual clinicians to try and adopt the tool with minimal financial commitment. Rapid PE Triage and Notification's pricing is not publicly disclosed and is typically enterprise-level, making it less accessible for individual practitioners or smaller clinics to assess its value proposition without direct contact.

PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, central report management, configurable user permissions, and robust security protocols (GDPR, HIPAA, SOC 2, ISO 27001). It is designed for system-wide cardiac care coordination across multiple pathways and sites. Rapid PE Triage and Notification also offers enterprise-level deployment (on-premise or cloud) and real-time notifications to clinicians via PACS, email, and mobile, indicating strong enterprise capabilities, but PMcardio's broader integration and management features suggest a more comprehensive enterprise solution.

PMcardio demonstrates significant innovation with its 'Queen of Hearts' STEMI and OMI detection, 'LVsense' for reduced LVEF detection, and 'ECGxplain' for visual AI explainability with heatmaps. It also offers automatic analysis of various ECG intervals and culprit artery confidence scores with 3D heart visualization. Rapid PE Triage and Notification's innovation lies in its rapid identification and notification of central pulmonary embolisms from CTPA images, which is valuable, but PMcardio's breadth of AI-powered diagnostic features and explainability tools appears more innovative in its field.

PMcardio provides a comprehensive 'Help Center' with instructions for use, FAQs, and regulatory documentation, including specific instructions for its AI ECG models in multiple languages. It also offers in-app support chat and resources like blogs and webinars. While RapidAI likely offers robust enterprise-level support, PMcardio's publicly available and detailed documentation, coupled with its individual user focus, suggests a more transparent and accessible support ecosystem.